Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ivy Healthcare Capital is a specialized private equity firm focused exclusively on the healthcare sector, primarily within the Chinese market. The firm invests across the entire healthcare value chain, including biotechnology, medical devices, in-vitro diagnostics, and healthcare services. Ivy Healthcare Capital partners with high-growth companies to provide strategic resources, operational expertise, and capital to help them scale in a competitive landscape. The firm's investment strategy emphasizes innovation and market leadership, aiming to address significant unmet medical needs. Its portfolio includes a diverse range of companies involved in cutting-edge medical technology and pharmaceutical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ivy Healthcare Capital.